Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 25, Issue 3, Pages 883-887Publisher
FRONTIERS MEDIA SA
DOI: 10.1007/s12253-017-0367-3
Keywords
Gastric cancer; EGOT; lncRNA; Tumorigenesis; Hedgehog
Funding
- Research Office of Jiangsu Cancer Hospital [ZK201401]
- Agency of Jiangsu Province Science and Technology [BK20151018]
Ask authors/readers for more resources
Gastric cancer (GC) is one of the mostly terminal malignancies with poor prognosis. Long noncoding RNA EGOT (EGOT) acts as a crucial regulator in the breast cancer. However, the function of EGOT in GC remains unknown. This work was to explore the clinical value and biological significance of EGOT in GC. EGOT levels in GC tissue and cell were analyzed by qRT-PCR. After knockdown of EGOT, GC cell growth and cycle progression were detected. The expression of EGOT was observably elevated in GC. Upregulation of EGOT was related with lymphatic metastasis and TNM stage. In addition, knockdown of EGOT by siRNA could significantly inhibit GC cell proliferation and arrest cycle progression in G1 phase. Moreover, EGOT mediated cyclin D1 expression in GC cells which was regulated by Hedgehog pathway. Further, loss of EGOT downregulated Hedgehog signaling pathway in GC cells. EGOT functions as an oncogene in GC, and may be useful as a conceivable diagnostic and prognostic biomarker for GC tumorigenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available